Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intravenous Injection”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00652418
What this trial is testing

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography

Who this might be right for
Magnetic Resonance AngiographyPeripheral Vascular DiseasesPeripheral Arterial Diseases
Bayer 12
Early research (Phase 1)Study completedNCT00000721
What this trial is testing

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Not applicableNot Yet RecruitingNCT03727555
What this trial is testing

IT and IV Lentiviral Gene Therapy for X-ALD

Who this might be right for
X-linked Adrenoleukodystrophy
Shenzhen Geno-Immune Medical Institute 30
Testing effectiveness (Phase 2)UnknownNCT00024414
What this trial is testing

DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Theradex
Large-scale testing (Phase 3)Study completedNCT00037206
What this trial is testing

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

Who this might be right for
Aspergillosis
Pfizer 30
Early research (Phase 1)Study completedNCT00931372
What this trial is testing

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 22
Testing effectiveness (Phase 2)Study completedNCT04189588
What this trial is testing

Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine

Who this might be right for
Oncology Patients Receiving Chemotherapy
TerSera Therapeutics LLC 34
Post-approval studies (Phase 4)Study completedNCT02095366
What this trial is testing

Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting

Who this might be right for
Severe Traumatic PainNumeric Pain Rating Scale > 5 / 10
University Hospital, Grenoble 194
Early research (Phase 1)Study completedNCT00001118
What this trial is testing

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableNot Yet RecruitingNCT07495150
What this trial is testing

Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis

Who this might be right for
Blood-Brain BarrierBacterial Meningitis
yilong Wang 86
Large-scale testing (Phase 3)Study completedNCT00354458
What this trial is testing

PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function

Who this might be right for
Heart Failure, Congestive
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 1,102
Early research (Phase 1)UnknownNCT05387226
What this trial is testing

Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma

Who this might be right for
T-cell LymphomaVirusIntravenous Injection
The First Affiliated Hospital of Bengbu Medical University 6
Early research (Phase 1)Study completedNCT07202871
What this trial is testing

How the Body Absorbs LY3537031

Who this might be right for
Healthy
Eli Lilly and Company 47
Early research (Phase 1)Study completedNCT01280240
What this trial is testing

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

Who this might be right for
Patients With Chemotherapy Induced Anemia (CIA)
Pharmacosmos A/S 11
Testing effectiveness (Phase 2)Looking for participantsNCT07682870
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Virogin Biotech Ltd. 42
Early research (Phase 1)Study completedNCT03055403
What this trial is testing

First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects

Who this might be right for
Healthy Volunteers
Yuji KUMAGAI 40
Early research (Phase 1)Study completedNCT04116840
What this trial is testing

Single Ascending Dose Trial to Evaluate the Safety, Tolerability, PK, and PD of MT1002 for Injection

Who this might be right for
Healthy
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 30
Early research (Phase 1)Ended earlyNCT03621605
What this trial is testing

A Phase1 Study of VIB9600

Who this might be right for
Safety Issues
Amgen 24
Post-approval studies (Phase 4)Study completedNCT02916927
What this trial is testing

Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department

Who this might be right for
Pain
Alameda Health System 62
Large-scale testing (Phase 3)Study completedNCT00433888
What this trial is testing

Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)

Who this might be right for
Hemodialysis Patients
Chugai Pharmaceutical 179
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation